Latest Commercial Modelling News

Memphasys has cleared a key regulatory hurdle in Vietnam for its Felix™ System, prompting a significant first commercial cartridge order and marking early clinical success in a fast-growing fertility market.

Mandrake Resources has started extracting bulk lithium brine from the Evelyn Chambers #1 well, advancing its Utah Lithium Project and providing critical data for future development.

EV Resources has locked in 200 tonnes of premium antimony ore near its Tecomatlán plant, setting the stage for its first commercial processing campaign under a five-year supply deal.

EVE Health Group has progressed its Libbo pilot clinical study for erectile dysfunction with dosing set for Q4 2026 and achieved a major solubility breakthrough for apixaban, while appointing Ben Rohr as CEO to drive commercial growth.

Memphasys secures exclusive Felix™ commercialisation agreement in Poland, marking its third European market entry with a two-year contract valued at approximately A$350,000.

Acusensus has landed a statewide contract in Kentucky to provide real-time speed enforcement at highway work zones, with initial orders worth US$2.1 million and potential expansion to US$20 million over five years.

Mandrake Resources has strategically refined its Utah Lithium Project tenure by securing three key SITLA leases in the project’s central zone and relinquishing marginal blocks, positioning itself for upcoming bulk lithium brine production and technical evaluation.

Enlitic slashed its net operating cash outflow by 76% in Q2 FY26 and secured binding commitments for a A$15 million conditional placement alongside convertible note conversions, positioning the company with a pro forma cash balance of about A$18 million and a debt-free balance sheet.

Artrya has launched its AI-powered Salix platform at Northeast Georgia Health System, marking its second U.S. commercial customer with active revenue streams from subscription and fee-per-scan models.

Lumos Diagnostics is accelerating the rollout of its rapid FebriDx test in the US, with a top 100 urgent care group deploying across 30+ sites and three tier 1 groups validating the test across 230+ locations.

Synertec has expanded its Powerhouse footprint with Santos, adding two new solar-plus-storage systems to power coal seam gas wells under a high-margin BOOM model.

Pacific Edge edges closer to Medicare reimbursement for its bladder cancer tests while its Asia Pacific operations show rising test volumes and improved margins, signaling a path toward profitability.